Mergers and Acquisitions

Celgene to buy Juno Therapeutics for $9B

Celgene Corp said on Monday it would pay about $9 billion in cash to acquire the rest of Juno Therapeutics Inc and gain access to Juno's experimental gene therapy to treat cancer.

Icahn, Deason Push for Xerox to Explore Sale

Investor Carl Icahn and Darwin Deason, major shareholders of Xerox, jointly plan to push the printer and photocopier maker to explore options, including a sale of the firm.

ADM has made takeover approach to Bunge Ltd

Archer Daniels Midland has made a takeover approach to Bunge Ltd., according to people familiar with the matter, setting up a possible bidding war after Glencore PLC earlier made an overture to the agricultural powerhouse.

ADM has made takeover approach to Bunge Ltd

Archer Daniels Midland has made a takeover approach to Bunge Ltd., according to people familiar with the matter, setting up a possible bidding war after Glencore PLC earlier made an overture to the agricultural powerhouse.

Judge rules for McClatchy officials accused of mismanagement

A California judge is siding with a former chief executive of the McClatchy newspaper chain and other company officials in a lawsuit alleging they mismanaged funds by buying a rival newspaper publisher and failing to diversify investments.

Viacom, CBS not in active discussions: report

Viacom and CBS are not in active merger discussions, although controlling shareholder Shari Redstone has had exploratory conversations with CBS directors about recombining the companies, Reuters said.